UBS Group’s The Beauty Health Company Warrant expiring 5/4/2026 SKINW Stock Holding History

UBS Group’s Portfolio SKINW Stock Details SKINW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$29K	–	11356
2021 Q3	$29K	Sell	2,000 -49,746	-96%	-$533K	﹤0.01%	6804
2021 Q2	$331K	Buy	51,746 +1,746	+3%	+$7.49K	﹤0.01%	5016
2021 Q1	$104K	Hold	50,000	–	–	﹤0.01%	5936
2020 Q4	$132K	Buy	+50,000	New	+$112K	﹤0.01%	5511

UBS Group's SKINW Position: Q4 2021 in Review

UBS Group sold out of The Beauty Health Company Warrant expiring 5/4/2026 (SKINW) in Q4 2021, closing a stake of 2,000 shares — an estimated $29K sold.

UBS Group first reported a position in SKINW in Q4 2020 and held it in 4 quarters. The position peaked at $331K in Q2 2021. 0 funds tracked by Wall St. Rank hold SKINW as of Q4 2021.

UBS Group reported no remaining The Beauty Health Company Warrant expiring 5/4/2026 position as of Q4 2021 after selling out during the quarter.
UBS Group sold 2,000 The Beauty Health Company Warrant expiring 5/4/2026 shares in Q4 2021, an estimated $29K.
UBS Group first reported a position in The Beauty Health Company Warrant expiring 5/4/2026 in Q4 2020 and held it in 4 quarters.
UBS Group's The Beauty Health Company Warrant expiring 5/4/2026 position peaked at $331K in Q2 2021.
0 funds tracked by Wall St. Rank held The Beauty Health Company Warrant expiring 5/4/2026 as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.